BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36375012)

  • 1. A Membrane Curvature Modulated Lipopeptide to Broadly Combat Multidrug-Resistant Bacterial Pneumonia with Low Resistance Risk.
    Zou P; Liu J; Li X; Yaseen M; Yao J; Liu L; Luo L; Wang H; Shi X; Li Z; Sun T; Gao Y; Gao C; Li LL
    ACS Nano; 2022 Dec; 16(12):20545-20558. PubMed ID: 36375012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
    Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
    J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
    Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
    Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
    Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
    Lee HR; You DG; Kim HK; Sohn JW; Kim MJ; Park JK; Lee GY; Yoo YD
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine.
    Zhao X; Zhong X; Yang S; Deng K; Liu L; Song X; Zou Y; Li L; Zhou X; Jia R; Lin J; Tang H; Ye G; Yang J; Zhao S; Lang Y; Wan H; Yin Z; Kuipers OP
    Antimicrob Agents Chemother; 2023 May; 67(5):e0001023. PubMed ID: 36912655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.
    Dugourd D; Yang H; Elliott M; Siu R; Clement JJ; Straus SK; Hancock RE; Rubinchik E
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3720-8. PubMed ID: 21576435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin.
    Lim AL; Miller BW; Lin Z; Fisher MA; Barrows LR; Haygood MG; Schmidt EW
    Microbiol Spectr; 2023 Dec; 11(6):e0230623. PubMed ID: 37882570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
    Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue.
    Quercini L; Brunetti J; Riolo G; Bindi S; Scali S; Lampronti I; D'Aversa E; Wronski S; Pollini S; Gentile M; Lupetti P; Rossolini GM; Falciani C; Bracci L; Pini A
    FASEB J; 2020 Jan; 34(1):192-207. PubMed ID: 31914681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
    Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
    Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic
    Wu KC; Hua KF; Yu YH; Cheng YH; Cheng TT; Huang YK; Chang HW; Chen WJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.